Vivencio Barrios

Summary

Country: Spain

Publications

  1. ncbi Candesartan: from left ventricular hypertrophy to heart failure, a global approach
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 5:825-34. 2007
  2. pmc Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Integr Blood Press Control 3:11-9. 2010
  3. pmc Emerging drug combinations to optimize renovascular protection and blood pressure goals
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Int J Nephrol Renovasc Dis 5:69-80. 2012
  4. ncbi Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Madrid 28034, Spain 34 91 336 8665
    Expert Opin Pharmacother 14:2249-61. 2013
  5. doi Patients with atrial fibrillation in a primary care setting: Val-FAAP study
    Vivencio Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Esp Cardiol (Engl Ed) 65:47-53. 2012
  6. ncbi [Risk factor control in the hypertensive patients with chronic ischemic heart disease attended in cardiologic outpatient clinics. The CINHTIA study]
    V Barrios
    En representación de la sección de Cardiología Clínica y Extrahospitalaria de la Sociedad Española de Cardiología
    Rev Clin Esp 208:400-4. 2008
  7. doi Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra, De Colmenar km 9, 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 6:1063-9. 2008
  8. doi Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 17:110-5. 2008
  9. doi Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra de Colmenar Km 9, 100, 28034 Madrid, Spain
    Expert Opin Pharmacother 11:1549-58. 2010
  10. pmc Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Vasc Health Risk Manag 5:723-9. 2009

Collaborators

Detail Information

Publications79

  1. ncbi Candesartan: from left ventricular hypertrophy to heart failure, a global approach
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 5:825-34. 2007
    ....
  2. pmc Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Integr Blood Press Control 3:11-9. 2010
    ..The aim of this manuscript is to update the published data on the efficacy and safety of this fixed combination...
  3. pmc Emerging drug combinations to optimize renovascular protection and blood pressure goals
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Int J Nephrol Renovasc Dis 5:69-80. 2012
    ..To date, RAS inhibitors recommended in this context are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Aliskiren, the first oral direct renin inhibitor available, has shown promising results...
  4. ncbi Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Madrid 28034, Spain 34 91 336 8665
    Expert Opin Pharmacother 14:2249-61. 2013
    ..The aim of this article was to review the available evidence about this drug alone or combined with other antihypertensive agents in the treatment of hypertensive population...
  5. doi Patients with atrial fibrillation in a primary care setting: Val-FAAP study
    Vivencio Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Esp Cardiol (Engl Ed) 65:47-53. 2012
    ..To assess the clinical characteristics of patients with atrial fibrillation in the primary care setting...
  6. ncbi [Risk factor control in the hypertensive patients with chronic ischemic heart disease attended in cardiologic outpatient clinics. The CINHTIA study]
    V Barrios
    En representación de la sección de Cardiología Clínica y Extrahospitalaria de la Sociedad Española de Cardiología
    Rev Clin Esp 208:400-4. 2008
    ..The CINHTIA study is a cross-sectional and multicentre survey designed to assess the clinical management of the hypertensive outpatients with chronic ischemic heart disease attended by cardiologists...
  7. doi Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra, De Colmenar km 9, 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 6:1063-9. 2008
    ..Less than 85% of physicians considered the efficacy and tolerability of combined therapy as 'good' or 'very good' but 93% of the patients were 'satisfied' or 'very satisfied' with combined therapy...
  8. doi Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 17:110-5. 2008
    ..g. Cornell voltage-duration product; CorP), is a good marker of LVH and the current study was designed to determine the prevalence of LVH in patients with essential hypertension treated in general practice...
  9. doi Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra de Colmenar Km 9, 100, 28034 Madrid, Spain
    Expert Opin Pharmacother 11:1549-58. 2010
    ....
  10. pmc Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Vasc Health Risk Manag 5:723-9. 2009
    ..This analysis assessed goal rate achievement in hypertensive patients receiving olmesartan-based treatment in the OLMEBEST study...
  11. doi Clinical profile and management of patients with chronic ischemic heart disease according to age in the population daily attended by cardiologists in Spain The ELDERCIC study
    Vivencio Barrios
    Vivencio Barrios, Dept of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Eur J Intern Med 21:180-4. 2010
    ..This study was aimed to evaluate the differences according to age in the clinical profile and management of outpatients with chronic ischemic heart disease attended by cardiologists in Spain...
  12. pmc High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Int J Clin Pract 62:723-8. 2008
    ....
  13. doi Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial
    Vivencio Barrios
    Department of Cardiology, Hospital Ramón Cajal, Madrid, Spain
    Clin Ther 30:98-107. 2008
    ....
  14. doi Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting
    Vivencio Barrios
    Cardiology Department, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 19:301-7. 2010
    ..To determine the proportion and clinical features of unrecognized heart failure (HF) in hypertensive women ≥65 years attended in Spain...
  15. ncbi Aliskiren: a new drug for an old problem
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Madrid, Spain
    Cardiovasc Hematol Agents Med Chem 8:1-10. 2010
    ..Aliskiren is a novel direct renin inhibitor with promising results. In this manuscript the current evidence about aliskiren, alone or in combination, is analyzed...
  16. doi Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMI
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Obesity (Silver Spring) 18:2017-22. 2010
    ..03) and diabetes control (38.6% vs. 27.6% vs. 22.2%, P = 0.023). In conclusion, in patients with hypertension and chronic ischemic heart disease, as BMI increases, the clinical profile worsens as well as risk factors control rates...
  17. doi Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra de Colmenar km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 7:1317-27. 2009
    ..In this paper, the efficacy and safety of rosuvastatin along the cardiovascular continuum is reviewed...
  18. doi Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Renin Angiotensin Aldosterone Syst 10:168-73. 2009
    ..This study examined the influence of diabetes on left ventricular hypertrophy (LVH) detected by different electrocardiographic (ECG) criteria and its changes induced by a 12-month candesartan-based regimen...
  19. doi Pulse pressure and the metabolic syndrome in patients with hypertension
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Cardiometab Syndr 4:72-5. 2009
    ..The odds ratio of having high PP in women with MetS vs no MetS was 3.13 and in men was 1.9 (both P<.01)...
  20. doi Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Drug Investig 29:427-39. 2009
    ....
  21. doi Importance of medication adherence from the ONTARGET and TRANSCEND points of view
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Fundam Clin Pharmacol 23:259-60. 2009
    ....
  22. ncbi Diabetes and hypertension. What is new?
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Minerva Cardioangiol 57:705-22. 2009
    ..In the present manuscript, the current data about the treatment of patients with hypertension and diabetes are reviewed...
  23. doi Sex differences in the hypertensive population with chronic ischemic heart disease
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Clin Hypertens (Greenwich) 10:779-86. 2008
    ..BP and LDL-C control rates, although poor in both groups, were better in men (44.9% vs 30.5%, P<.001 and 33.0% vs 25.0%, P<.001, respectively). Stress testing and coronary angiography were more frequently performed in men...
  24. pmc Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Vasc Health Risk Manag 4:847-53. 2008
    ..The aim of this manuscript is to update the published data about the efficacy and safety of this fixed combination...
  25. doi Gender differences in the diagnosis and treatment of left ventricular hypertrophy detected by different electrocardiographic criteria. Findings from the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Heart Vessels 25:51-6. 2010
    ..Although in daily clinical practice the use of both product criteria seemed clearly preferable to voltage for assessment of ECG-LVH, the CorP appeared to be markedly more useful in women and SokP in men...
  26. ncbi [Impact of the presence of cardiovascular disease on blood pressure and lipid control in the hypertense population attended in primary care]
    Vivencio Barrios Alonso
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Madrid, Espana
    Aten Primaria 40:21-7. 2008
    ....
  27. ncbi Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Expert Opin Pharmacother 9:129-36. 2008
    ..5 mg is the latest combination of an angiotensin receptor blocker and a diuretic approved for treatment of hypertension. The aim of this manuscript is to update the published data about the efficacy and safety of this fixed combination...
  28. pmc Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Int J Clin Pract 60:1364-70. 2006
    ..Lercanidipine was effective and well-tolerated in patients with mild-to-moderate hypertension in the daily practice. The effectiveness and safety of the drug were independent of the degree of cardiovascular risk...
  29. ncbi [ARB II in chronic heart failure. Coincidences and divergences. Class effect?]
    V Barrios Alonso
    Instituto de Cardiologia, Hospital Universitario Ramon y Cajal, Madrid
    Rev Clin Esp 205:499-506. 2005
    ..However, new information of the already finished studies and some still on-going clinical trials may help us to know the effects of the ARB II in this disease more and better...
  30. doi Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Hypertens 26:2230-5. 2008
    ..The present study was designed to assess the influence of renal function on the clinical profile and management of the hypertensive outpatients with chronic ischemic heart disease...
  31. doi Diltiazem in the treatment of hypertension and ischemic heart disease
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 9:1375-82. 2011
    ..In this article, available evidence regarding diltiazem in the treatment of hypertension and ischemic heart disease is updated...
  32. ncbi [Hypertension and heart failure in Primary Care and Cardiology consultations of in Spain]
    V Barrios Alonso
    Sección de Hipertensión Arterial Sociedad Española de Cardiología, Madrid, Spain
    Rev Clin Esp 203:334-42. 2003
    ..Analyze the results concerning the heart failure population of CARDIOTENS 99, a cross-sectional study of hypertension associated with cardiovascular disease carried out on 32,051 patients seen in Cardiology and Primary Care consultations...
  33. ncbi [Utility of angiotensin receptor blockers in heart failure]
    V Barrios Alonso
    Instituto de Cardiologia, Hospital Ramon y Cajal, Ctra Colmenar, Km 9 100, 28034 Madrid, Spain
    Rev Clin Esp 203:28-32. 2003
  34. ncbi N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 11:235-9. 2002
    ..This effect may be mediated by an NO-dependent mechanism, probably through the protective effect of NAC on NO oxidation...
  35. ncbi [Tolerability and efficiency of a new transdermic nitroglycerin patch in outpatients with chronic stable angina. The PATRICH Trial]
    V Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Clin Esp 202:379-84. 2002
    ..To obtain data on local and systemic tolerability of three different doses (5 mg/24 h, 10 mg/24 h, and 15 mg/24 h) of a new model of nitroglycerin patch (Trinipatch, Sanofi-Synthelabo, S. A.) in patients with chronic stable angina...
  36. ncbi Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad
    Vivencio Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 11:95-100. 2002
    ..With the aim to determine the efficacy and tolerability of this drug in usual clinical practice we performed the ELYPSE trial...
  37. ncbi [Prevention of atrial fibrillation in hypertensive patients]
    Vivencio Barrios Alonso
    Instituto de Cardiologia, Hospital Ramon y Cajal Madrid, Espana
    Med Clin (Barc) 128:148-54. 2007
    ..Data show that both, ACEIs and ARBs, appear effective to prevent AF. However, a lack of prospective randomized double-blind trials data limits their application in absence of any other indication...
  38. ncbi Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Hum Hypertens 21:479-85. 2007
    ..GPs and specialists tend to underestimate the cardiovascular risk in daily clinical practice, mainly in very high-risk patients...
  39. ncbi Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, Madrid 28034, Spain
    J Renin Angiotensin Aldosterone Syst 7:236-42. 2006
    ..Thus, a candesartan-based regimen for six months significantly reduced echocardiographic LVH in hypertensive patients in general practice. The drug was very well tolerated and no serious adverse events were reported...
  40. ncbi Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Hypertens 25:1967-73. 2007
    ..The aim of the SARA study was to investigate the effect of an ARB on electrocardiographic LVH (ECG-LVH) in a hypertensive outpatient population attending clinical practice...
  41. ncbi Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Cardiometab Syndr 2:9-15. 2007
    ..5% for non-metabolic syndrome patients (P<.0001). These findings demonstrate that the metabolic syndrome is common in patients with hypertension and that it is generally poorly diagnosed and treated by primary care physicians...
  42. ncbi [Adequacy of the treatment of hypertensive patients with metabolic syndrome]
    Vivencio Barrios
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Madrid, Espana
    Med Clin (Barc) 128:647-51. 2007
    ....
  43. ncbi Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Clin Hypertens (Greenwich) 9:324-9. 2007
    ..The BP and LDL-C control rates in the hypertensive population attended to daily in primary care settings in Spain are low...
  44. doi [Computerized interpretation of the electrocardiogram in the diagnosis of left ventricular hypertrophy. The ELECTROPRES project]
    V Barrios
    Instituto de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Clin Esp 211:391-9. 2011
    ..This study has aimed to assess the impact of the computerized interpretation of the ECG on the diagnosis of LVH in the practical clinical setting...
  45. doi Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 9:579-85. 2011
    ..To assess the predictive value of B-type natriuretic peptide (BNP) in the diagnosis of heart failure (HF) in a primary-care setting in Spain...
  46. doi Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Madrid, Spain
    Expert Opin Drug Saf 10:957-68. 2011
    ....
  47. doi Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Cardiovasc Ther 26:2-9. 2008
    ..8% vs. 3.6%). In conclusion, treatment with lercanidipine at high doses is associated with a lower rate of adverse events related to vasodilation compared to high doses of amlodipine or nifedipine GITS in clinical practice...
  48. ncbi Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study
    Carlos Escobar
    Department of Cardiology, Hospital Ramon y Cajal, Carretera Colmenar km 9 100, Madrid, Spain
    J Clin Hypertens (Greenwich) 10:208-14. 2008
    ..5% (P=.01). The relative risk reduction of ECG-LVH was higher in patients with MS according to CorV and SokP criteria (P<.01)...
  49. ncbi Effect of candesartan on coronary flow reserve in patients with systemic hypertension
    Juan Pablo Tomás
    Department of Cardiology, Ramon y Cajal Hospital, Madrid, Spain
    J Hypertens 24:2109-14. 2006
    ..The aim of this study was to evaluate, non-invasively, the effect of candesartan on coronary microvascular function in hypertensive patients...
  50. doi Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study
    Alberto Calderon
    CS Rosa Luxemburgo, 5th Sanitary Area, Madrid, Spain
    Clin Exp Hypertens 32:145-53. 2010
    ..The combinations of the Cornell product with the Sokolow voltage or with the Sokolow product appear to be the most efficient options...
  51. ncbi Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone
    Hector F Escobar-Morreale
    Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain
    Ann Intern Med 142:412-24. 2005
    ..Substituting part of the dose of l-thyroxine with small but supraphysiologic doses of liothyronine in hypothyroid patients has yielded conflicting results...
  52. doi Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1609-18. 2010
    ..In this article, available evidence about the efficacy and tolerability of the triple fixed combined therapy valsartan-amlodipine-hydrochlorothiazide for the treatment of hypertension is updated...
  53. doi An evaluation of the latest evidence relating to renin-angiotensin system inhibitors
    Carlos Escobar
    Hospital La Paz, Department of Cardiology, Madrid, Spain
    Expert Opin Drug Metab Toxicol 9:847-58. 2013
    ..In the last few years, a number of important clinical trials have been completed that have investigated the inhibition of the renin-angiotensin system. New drugs, focusing on this system, have now emerged as a result...
  54. ncbi [PREVENCAT study: control of cardiovascular risk in primary care]
    Luis A Alvarez-Sala
    Departamento de Medicina, Hospital General Universitario Gregorio Maranon, Facultad de Medicina, Universidad Complutense, Madrid, Spain
    Med Clin (Barc) 124:406-10. 2005
    ....
  55. doi Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism
    Carlos Escobar
    Unidad de Ecocardiografía, Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:244-50. 2008
    ..The aim of this study was to determine the prognostic value of electrocardiography in hemodynamically stable patients with a diagnosis of acute symptomatic pulmonary embolism (PE)...
  56. doi Can dabigatran improve blood pressure control?
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Future Cardiol 9:321-3. 2013
    ..In this report, the possible mechanisms that may explain this change are discussed...
  57. doi Diabetes and hypertension: which is the best approach?
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Expert Rev Cardiovasc Ther 7:269-71. 2009
    ..In this article the potential explanations of these results are discussed...
  58. ncbi Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Drug Investig 27:545-58. 2007
    ....
  59. doi Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain
    Vivencio Barrios
    Cardiology Department, Hospital Ramon y Cajal, Madrid, Spain
    J Med Econ 15:45-54. 2012
    ....
  60. doi Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study
    Beatriz de Rivas
    Medical Department, AstraZeneca, Madrid, Spain
    J Clin Hypertens (Greenwich) 12:335-44. 2010
    ..More complex and intensive programs are needed for this type of prevention...
  61. doi Aliskiren in the management of hypertension
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Am J Cardiovasc Drugs 10:349-58. 2010
    ..Moreover, this agent reduces plasma renin activity, which in theory could have additional clinical benefits. However, clinical trials analyzing the effects of aliskiren on mortality are still ongoing...
  62. pmc Relative safety profiles of high dose statin regimens
    Carlos Escobar
    Department of Cardiology, Hospital Ramon y Cajal Madrid, Spain
    Vasc Health Risk Manag 4:525-33. 2008
    ..During recent years, numerous trials to analyze the efficacy and tolerability of high doses of statins have been published. This paper updates the published data on the safety of statins at high doses...
  63. doi Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:129-41. 2013
    ..This article provides an extensive review of the available evidence about rivaroxaban, with a special focus on nonvalvular AF...
  64. doi Diagnostic accuracy of computer-assisted electrocardiography in the diagnosis of left ventricular hypertrophy in left bundle branch block
    Luis Rodriguez-Padial
    Servicio de Cardiologia, Hospital Virgen de la Salud, Toledo, Espana
    Rev Esp Cardiol (Engl Ed) 65:38-46. 2012
    ..Although electrocardiography is the technique most often recommended in the diagnosis of hypertrophy, its diagnostic accuracy is hampered in the presence of a left bundle branch block...
  65. doi Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid
    Cardiovasc Ther 28:295-301. 2010
    ..The aim of this review is to update information on the prevention of thromboembolic events in patients with AF and how dabigatran may change daily clinical practice...
  66. doi Combined therapy in the treatment of hypertension
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Fundam Clin Pharmacol 24:3-8. 2010
    ..In the present study, available evidence about the efficacy and tolerability of combined therapy for the treatment of hypertension is updated...
  67. ncbi [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study]
    Vivencio Barrios
    Departamento de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol 61:1159-67. 2008
    ..This study investigated how the levels of adiponectin and other emerging risk factors are related to CV events in the Spanish population...
  68. doi Antihypertensive and organ-protective effects of benazepril
    Vivencio Barrios
    Department of Cardiology, University Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1653-71. 2010
    ..Differences between combination therapies have implications for which patients may be best suited to particular interventions, and further studies are required to fully ascertain this potential...
  69. doi Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism
    David Jimenez
    Respiratory Department, Ramon y Cajal Hospital, IRYCIS, Madrid, Spain
    Thorax 66:75-81. 2011
    ....
  70. ncbi [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia]
    Juan P Tomas
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol 57:909-15. 2004
    ..The aim of this study was to use this noninvasive technique to evaluate the effect of atorvastatin on peripheral endothelial function and on the coronary microvasculature in patients with dyslipidemia...
  71. ncbi [Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism]
    Carlos Escobar
    Unidad de Ecocardiografía, Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Esp Cardiol 61:244-50. 2008
    ..The aim of this study was to determine the prognostic value of electrocardiography in hemodynamically stable patients with a diagnosis of acute symptomatic pulmonary embolism (PE)...
  72. ncbi [Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study]
    V Barrios
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Carretera de Colmenar, 28034 Madrid, Spain
    Rev Clin Esp 207:172-8. 2007
    ..Good blood pressure control was considered <140/90 mmHg (<130/80 mmHg for diabetics) and LDL-c according to the established by ATP-III for every risk group...
  73. ncbi Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma
    José I Botella-Carretero
    Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain
    Endocr Relat Cancer 11:345-56. 2004
    ....
  74. ncbi [Diabetes mellitus in hypertensive population attended in Primary Care in Spain. Blood pressure and lipid control rates]
    C Escobar
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Carretera del Colmenar km 9, 100, 28034 Madrid, Spain
    Rev Clin Esp 207:221-7. 2007
    ....
  75. ncbi Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure
    L M Ruilope
    Unidad de Hipertension, Hospital 12 de Octubre, Madrid, Spain
    J Hypertens 18:1545-51. 2000
    ..The systematic therapeutic use of drug(s) provided with beneficial renal effects, to treat arterial hypertension or myocardial ischemia, may contribute to delay of, or prevent the development of HF...
  76. ncbi [Prevalence of undetected chronic kidney disease in dyslipidemic population treated in primary care. LIPICAP study]
    Jose L Llisterri Caro
    Centro de Salud Joaquín Benlloch, Valencia, Espana
    Med Clin (Barc) 130:127-32. 2008
    ..The aim of this study was to determine undetected CKD prevalence in dyslipidemic population measuring creatinine clearance according to the Cockcroft-Gault equation corrected for surface area...
  77. ncbi [Role of new drug combinations at fixed doses for the management of arterial hypertension]
    José Luis Llisterri Caro
    Centro de Salud Ingeniero Joaquín Benlloch, Valencia, Espana
    Med Clin (Barc) 130:342-4. 2008
  78. ncbi [Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study]
    Jose L Llisterri Caro
    Centro de Salud de Ingeniero Joaquín Benlloch, Valencia, Espana
    Med Clin (Barc) 130:681-7. 2008
    ..This study aimed to determine the degree of blood pressure (BP) control in Spanish hypertensive patients attended in primary care (PC) and to determine the factors associated with poor BP control...
  79. ncbi [2003 update of the Guidelines of the Spanish Society of Cardiology on High Blood Pressure]
    Jose Ramon Gonzalez-Juanatey
    Sección de Hipertensión Arterial de la Sociedad Española de Cardiología Madrid España
    Rev Esp Cardiol 56:487-97. 2003
    ..Those with diabetes or left ventricular hypertrophy seem to benefit from pharmacological block of the renin-angiotensin system, and patients with heart failure from combined therapy with ACE inhibitors plus beta-blockers...